Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(40 sites)

France

Institut de cancérologie de l'Ouest, Angers

Clinique Sainte Catherine, Avignon

Centre Hospitalier de la Côte Basque, Bayonne

CHU Besançon, Besançon

CHU Bordeaux - Hôpial Saint André, Bordeaux